Biosimilar PharmaceuticalsTherapeutic EquivalencyLegislation, DrugDrug ApprovalBiological ProductsDrug IndustryDrugs, GenericProduct Surveillance, PostmarketingPharmacovigilanceEuropean UnionImmunogenetic PhenomenaDrug and Narcotic ControlGranulocyte Colony-Stimulating FactorChemistry Techniques, AnalyticalPharmaceutical PreparationsGuidelines as TopicRecombinant ProteinsDrug-Related Side Effects and Adverse Reactions